/PRNewswire/ Approximately 37 million Americans have chronic kidney disease (CKD) that is one out of every seven U.S. adults.1 Many of these patients are.
/PRNewswire/ Glomerulonephritis is a major contributor of end-stage renal disease across the globe, with IgA nephropathy (IgAN), also known as Berger s.
/PRNewswire/ The European regulatory authorities tend to be moving in a different direction than U.S. Food and Drug Administration (FDA) regarding novel.
/PRNewswire/ Spherix Global Insights, a leading market intelligence firm specializing in immunology-based research and insights, recently published several.
/PRNewswire/ Glomerulonephritis is a major contributor of end-stage renal disease across the globe, with IgA nephropathy (IgAN), also known as Berger s.